Atossa Therapeutics: Wainwright Raises Buy Rating to $25 from $7

Thursday, Mar 26, 2026 8:17 am ET1min read
ATOS--

Atossa Therapeutics: Wainwright Raises Buy Rating to $25 from $7

Atossa Therapeutics: Wainwright Raises Buy Rating to $25 from $7

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet